CME Group Inc (NASDAQ:CME) Shares Sold by AGF Investments Inc.

AGF Investments Inc. decreased its holdings in shares of CME Group Inc (NASDAQ:CME) by 21.1% in the 2nd quarter, according to the company in its …

CME Group logoAGF Investments Inc. decreased its holdings in shares of CME Group Inc (NASDAQ:CME) by 21.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,500 shares of the financial services provider’s stock after selling 400 shares during the period. AGF Investments Inc.’s holdings in CME Group were worth $291,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently bought and sold shares of the business. Independent Advisor Alliance raised its holdings in CME Group by 5.9% during the first quarter. Independent Advisor Alliance now owns 1,947 shares of the financial services provider’s stock valued at $321,000 after acquiring an additional 108 shares during the period. Fox Run Management L.L.C. purchased a new position in CME Group in the second quarter worth about $571,000. Jackson Hole Capital Partners LLC grew its position in CME Group by 4.1% in the first quarter. Jackson Hole Capital Partners LLC now owns 1,986 shares of the financial services provider’s stock worth $327,000 after acquiring an additional 79 shares in the last quarter. KC Investment Advisors LLC grew its position in CME Group by 9.0% in the first quarter. KC Investment Advisors LLC now owns 2,898 shares of the financial services provider’s stock worth $477,000 after acquiring an additional 240 shares in the last quarter. Finally, United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund grew its position in CME Group by 609.0% in the first quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund now owns 122,785 shares of the financial services provider’s stock worth $20,208,000 after acquiring an additional 105,468 shares in the last quarter. 85.72% of the stock is owned by institutional investors.

Several research analysts recently commented on the company. Deutsche Bank lifted their price target on CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. UBS Group lifted their price target on CME Group from $190.00 to $194.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 3rd. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a research report on Friday, August 9th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating and set a $158.00 price target for the company. in a research report on Monday, May 27th. Finally, Wells Fargo & Co lifted their price target on CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research report on Wednesday, July 3rd. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have issued a buy rating to the stock. CME Group has an average rating of “Hold” and an average target price of $194.00.

Shares of CME opened at $215.76 on Thursday. The company’s fifty day moving average price is $207.88 and its 200-day moving average price is $188.20. The firm has a market capitalization of $75.64 billion, a PE ratio of 31.64, a price-to-earnings-growth ratio of 4.70 and a beta of 0.23. CME Group Inc has a 1-year low of $161.05 and a 1-year high of $217.65. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.05 and a quick ratio of 1.05.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.75 by $0.01. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The company’s revenue was up 20.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.74 earnings per share. As a group, research analysts anticipate that CME Group Inc will post 6.68 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be given a $0.75 dividend. The ex-dividend date is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.39%. CME Group’s dividend payout ratio (DPR) is currently 43.99%.

In related news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the completion of the transaction, the chief executive officer now owns 79,057 shares in the company, valued at approximately $15,823,258.55. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Kevin Kometer sold 16,140 shares of the company’s stock in a transaction dated Friday, June 7th. The stock was sold at an average price of $201.19, for a total transaction of $3,247,206.60. Following the transaction, the insider now owns 72,122 shares of the company’s stock, valued at approximately $14,510,225.18. The disclosure for this sale can be found here. In the last quarter, insiders sold 76,771 shares of company stock valued at $15,398,375. Insiders own 1.20% of the company’s stock.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: Why is total return important?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

First Merchants Corp Has $390000 Stock Holdings in CME Group Inc (NASDAQ:CME)

First Merchants Corp cut its position in shares of CME Group Inc (NASDAQ:CME) by 8.7% in the second quarter, according to the company in its most …

CME Group logoFirst Merchants Corp cut its position in shares of CME Group Inc (NASDAQ:CME) by 8.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,008 shares of the financial services provider’s stock after selling 192 shares during the period. First Merchants Corp’s holdings in CME Group were worth $390,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. Truvestments Capital LLC purchased a new stake in CME Group during the first quarter valued at approximately $32,000. Close Asset Management Ltd purchased a new stake in CME Group during the first quarter valued at approximately $34,000. Westside Investment Management Inc. purchased a new stake in CME Group during the second quarter valued at approximately $38,000. Permanens Capital L.P. purchased a new stake in CME Group during the first quarter valued at approximately $41,000. Finally, Berman Capital Advisors LLC raised its holdings in shares of CME Group by 23.9% in the first quarter. Berman Capital Advisors LLC now owns 342 shares of the financial services provider’s stock worth $56,000 after buying an additional 66 shares during the period. 85.72% of the stock is owned by institutional investors.

In other news, COO Julie Holzrichter sold 4,241 shares of the business’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $192.26, for a total value of $815,374.66. Following the completion of the sale, the chief operating officer now owns 46,113 shares of the company’s stock, valued at approximately $8,865,685.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the completion of the transaction, the chief executive officer now directly owns 79,057 shares of the company’s stock, valued at $15,823,258.55. The disclosure for this sale can be found here. In the last quarter, insiders sold 76,771 shares of company stock worth $15,398,375. 1.20% of the stock is owned by company insiders.

CME has been the topic of several recent analyst reports. UBS Group increased their price target on CME Group from $190.00 to $194.00 and gave the stock a “neutral” rating in a report on Wednesday, July 3rd. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research report on Friday, August 9th. Barclays increased their target price on CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a research report on Thursday, May 23rd. Deutsche Bank increased their target price on CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a research report on Friday, August 9th. Finally, Wells Fargo & Co raised their price objective on CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research report on Wednesday, July 3rd. Three equities research analysts have rated the stock with a sell rating, five have given a hold rating and eight have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $194.00.

Shares of CME stock opened at $215.76 on Thursday. CME Group Inc has a 12 month low of $161.05 and a 12 month high of $217.65. The company has a market cap of $75.64 billion, a P/E ratio of 31.64, a PEG ratio of 4.70 and a beta of 0.23. The firm has a fifty day moving average price of $207.88 and a 200 day moving average price of $188.20. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.15.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The firm had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. During the same period in the prior year, the company posted $1.74 earnings per share. The firm’s revenue for the quarter was up 20.1% on a year-over-year basis. On average, equities analysts forecast that CME Group Inc will post 6.68 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.39%. CME Group’s dividend payout ratio (DPR) is presently 43.99%.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: Market Perform

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

CME Group Inc (NASDAQ:CME) CEO Sells $7005250.00 in Stock

CME Group Inc (NASDAQ:CME) CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction on Thursday, August 1st. The stock …

CME Group logoCME Group Inc (NASDAQ:CME) CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the completion of the sale, the chief executive officer now owns 79,057 shares of the company’s stock, valued at $15,823,258.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Shares of CME traded down $0.46 during mid-day trading on Wednesday, hitting $215.76. 690,651 shares of the company traded hands, compared to its average volume of 1,581,974. CME Group Inc has a one year low of $161.05 and a one year high of $217.65. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.15. The business has a 50-day moving average of $207.88 and a 200 day moving average of $188.20. The stock has a market capitalization of $75.64 billion, a price-to-earnings ratio of 31.64, a PEG ratio of 4.70 and a beta of 0.23.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The business had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.27 billion. During the same period in the prior year, the firm earned $1.74 earnings per share. CME Group’s revenue was up 20.1% compared to the same quarter last year. As a group, analysts anticipate that CME Group Inc will post 6.68 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be paid a $0.75 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a yield of 1.39%. CME Group’s payout ratio is presently 43.99%.

A number of hedge funds have recently made changes to their positions in the business. Independent Advisor Alliance increased its stake in CME Group by 5.9% in the 1st quarter. Independent Advisor Alliance now owns 1,947 shares of the financial services provider’s stock valued at $321,000 after buying an additional 108 shares during the last quarter. First United Bank Trust increased its stake in CME Group by 2.5% in the 1st quarter. First United Bank Trust now owns 7,725 shares of the financial services provider’s stock valued at $1,271,000 after buying an additional 185 shares during the last quarter. Fox Run Management L.L.C. acquired a new stake in CME Group in the 2nd quarter valued at $571,000. Jackson Hole Capital Partners LLC increased its stake in CME Group by 4.1% in the 1st quarter. Jackson Hole Capital Partners LLC now owns 1,986 shares of the financial services provider’s stock valued at $327,000 after buying an additional 79 shares during the last quarter. Finally, Aperio Group LLC increased its stake in CME Group by 3.7% in the 2nd quarter. Aperio Group LLC now owns 210,967 shares of the financial services provider’s stock valued at $40,951,000 after buying an additional 7,573 shares during the last quarter. 85.72% of the stock is currently owned by hedge funds and other institutional investors.

Several research firms recently weighed in on CME. Citigroup set a $202.00 target price on shares of CME Group and gave the company a “buy” rating in a research note on Thursday, May 2nd. Deutsche Bank increased their target price on shares of CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a research note on Friday, August 9th. UBS Group increased their target price on shares of CME Group from $190.00 to $194.00 and gave the company a “neutral” rating in a research note on Wednesday, July 3rd. Barclays increased their target price on shares of CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a research note on Thursday, May 23rd. Finally, Wells Fargo & Co increased their target price on shares of CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a research note on Wednesday, July 3rd. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $194.00.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Story: How to Invest in Growth Stocks

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Bessemer Group Inc. Sells 194699 Shares of CME Group Inc (NASDAQ:CME)

Bessemer Group Inc. lowered its position in shares of CME Group Inc (NASDAQ:CME) by 20.0% during the second quarter, according to the company …

CME Group logoBessemer Group Inc. lowered its position in shares of CME Group Inc (NASDAQ:CME) by 20.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 778,779 shares of the financial services provider’s stock after selling 194,699 shares during the quarter. Bessemer Group Inc. owned approximately 0.22% of CME Group worth $151,171,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. FMR LLC grew its holdings in CME Group by 5.7% during the 1st quarter. FMR LLC now owns 6,553,654 shares of the financial services provider’s stock worth $1,078,600,000 after acquiring an additional 355,566 shares in the last quarter. Janus Henderson Group PLC grew its holdings in CME Group by 10.7% during the 1st quarter. Janus Henderson Group PLC now owns 6,229,661 shares of the financial services provider’s stock worth $1,025,278,000 after acquiring an additional 603,645 shares in the last quarter. Geode Capital Management LLC grew its holdings in CME Group by 12.9% during the 4th quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock worth $885,776,000 after acquiring an additional 537,917 shares in the last quarter. Northern Trust Corp grew its holdings in CME Group by 1.0% during the 1st quarter. Northern Trust Corp now owns 4,212,490 shares of the financial services provider’s stock worth $693,291,000 after acquiring an additional 42,753 shares in the last quarter. Finally, Fiera Capital Corp grew its holdings in CME Group by 7.2% during the 1st quarter. Fiera Capital Corp now owns 2,531,242 shares of the financial services provider’s stock worth $416,592,000 after acquiring an additional 169,830 shares in the last quarter. Hedge funds and other institutional investors own 85.72% of the company’s stock.

Shares of CME stock traded down $2.02 during midday trading on Friday, reaching $211.22. 1,257,705 shares of the company were exchanged, compared to its average volume of 1,342,990. CME Group Inc has a 12 month low of $161.05 and a 12 month high of $217.65. The company has a market cap of $76.36 billion, a P/E ratio of 30.97, a PEG ratio of 4.75 and a beta of 0.23. The company’s 50 day moving average price is $206.79 and its two-hundred day moving average price is $187.33. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.05 and a current ratio of 1.05.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, topping analysts’ consensus estimates of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The company had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the previous year, the firm earned $1.74 EPS. CME Group’s revenue was up 20.1% on a year-over-year basis. As a group, sell-side analysts predict that CME Group Inc will post 6.68 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.42%. CME Group’s payout ratio is currently 43.99%.

Several research analysts have recently commented on CME shares. Barclays lifted their price target on shares of CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a report on Thursday, May 23rd. Deutsche Bank lifted their price target on shares of CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a report on Friday, August 9th. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price target for the company. in a report on Monday, May 27th. ValuEngine raised shares of CME Group from a “hold” rating to a “buy” rating in a report on Wednesday, May 8th. Finally, Citigroup set a $202.00 target price on shares of CME Group and gave the company a “buy” rating in a research note on Thursday, May 2nd. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and eight have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $194.00.

In other news, insider Sunil Cutinho sold 1,990 shares of CME Group stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $202.38, for a total value of $402,736.20. Following the transaction, the insider now directly owns 31,182 shares of the company’s stock, valued at $6,310,613.16. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Dennis Suskind sold 1,500 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $212.46, for a total transaction of $318,690.00. Following the transaction, the director now directly owns 4,853 shares in the company, valued at $1,031,068.38. The disclosure for this sale can be found here. Insiders sold a total of 76,271 shares of company stock worth $15,290,370 over the last quarter. Insiders own 1.20% of the company’s stock.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: Outstanding Shares

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Cpwm LLC Sells 493 Shares of CME Group Inc (NASDAQ:CME)

Cpwm LLC trimmed its position in CME Group Inc (NASDAQ:CME) by 7.8% during the second quarter, according to the company in its most recent …

CME Group logoCpwm LLC trimmed its position in CME Group Inc (NASDAQ:CME) by 7.8% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,856 shares of the financial services provider’s stock after selling 493 shares during the period. Cpwm LLC’s holdings in CME Group were worth $1,137,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of CME. Close Asset Management Ltd purchased a new position in shares of CME Group during the 1st quarter valued at approximately $34,000. Advantage Investment Management LLC boosted its stake in shares of CME Group by 119.0% during the 2nd quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock valued at $36,000 after buying an additional 100 shares during the last quarter. Westside Investment Management Inc. purchased a new position in shares of CME Group during the 2nd quarter valued at approximately $38,000. Permanens Capital L.P. acquired a new stake in shares of CME Group during the 1st quarter valued at approximately $41,000. Finally, Berman Capital Advisors LLC raised its position in shares of CME Group by 23.9% during the 1st quarter. Berman Capital Advisors LLC now owns 342 shares of the financial services provider’s stock valued at $56,000 after acquiring an additional 66 shares in the last quarter. Hedge funds and other institutional investors own 85.72% of the company’s stock.

Several research firms recently issued reports on CME. Wells Fargo & Co upped their price target on CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a research report on Wednesday, July 3rd. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating and set a $158.00 target price on the stock. in a research report on Monday, May 27th. Barclays raised their price target on CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a report on Thursday, May 23rd. ValuEngine raised CME Group from a “hold” rating to a “buy” rating in a report on Wednesday, May 8th. Finally, BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a report on Friday, August 9th. Three analysts have rated the stock with a sell rating, five have issued a hold rating and eight have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $194.00.

NASDAQ CME traded down $2.02 during trading on Friday, reaching $211.22. 1,257,705 shares of the company’s stock were exchanged, compared to its average volume of 1,342,990. CME Group Inc has a fifty-two week low of $161.05 and a fifty-two week high of $217.65. The company’s fifty day simple moving average is $206.79 and its 200-day simple moving average is $187.33. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.15. The firm has a market capitalization of $76.36 billion, a PE ratio of 30.97, a P/E/G ratio of 4.75 and a beta of 0.23.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.75 by $0.01. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The company had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same period last year, the business earned $1.74 EPS. The business’s quarterly revenue was up 20.1% on a year-over-year basis. Equities analysts forecast that CME Group Inc will post 6.68 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Tuesday, September 10th will be paid a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 43.99%.

In other CME Group news, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $200.15, for a total value of $7,005,250.00. Following the sale, the chief executive officer now owns 79,057 shares of the company’s stock, valued at approximately $15,823,258.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy S. Bitsberger sold 700 shares of the firm’s stock in a transaction that occurred on Tuesday, June 4th. The shares were sold at an average price of $194.35, for a total value of $136,045.00. Following the completion of the sale, the director now directly owns 9,421 shares in the company, valued at approximately $1,830,971.35. The disclosure for this sale can be found here. Insiders have sold a total of 76,271 shares of company stock valued at $15,290,370 over the last ninety days. Company insiders own 1.20% of the company’s stock.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: How are Outstanding Shares Different from Authorized Shares?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts